Albumin enhances the diffusion of lipophilic drugs into the membrane bilayer
- PMID: 15964025
- DOI: 10.1016/j.lfs.2005.05.008
Albumin enhances the diffusion of lipophilic drugs into the membrane bilayer
Abstract
In earlier work, we reported on the manner with which lipophilic drug molecules interact with the cell membrane in order to (a) enter the bilayer and laterally diffuse to their respective protein sites of action, or (b) penetrate this biological barrier to reach the cell interior. A remaining uncertainty is how lipophilic molecules reach the hydrophobic membrane core after traversing the aqueous medium and membrane polar surface. Here we present preliminary data using deuterium NMR, demonstrating the role of bovine serum albumin in facilitating this process. Our observation allows us to postulate a mechanism by which the passive transport of lipophilic ligands across the membrane can be greatly enhanced through the assistance of carrier proteins.
Similar articles
-
How lipophilic cannabinergic ligands reach their receptor sites.Prostaglandins Other Lipid Mediat. 2005 Sep;77(1-4):210-8. doi: 10.1016/j.prostaglandins.2004.01.010. Prostaglandins Other Lipid Mediat. 2005. PMID: 16099405 Review.
-
Uptake and translocation mechanisms of cationic amino derivatives functionalized on pristine C60 by lipid membranes: a molecular dynamics simulation study.ACS Nano. 2011 Nov 22;5(11):8571-8. doi: 10.1021/nn201952c. Epub 2011 Oct 13. ACS Nano. 2011. PMID: 21981729
-
The diffusion of molecules in axonal plasma membranes: the sites of insertion of new membrane molecules and their distribution along the axon surface.J Theor Biol. 1998 Aug 7;193(3):371-82. doi: 10.1006/jtbi.1998.0707. J Theor Biol. 1998. PMID: 9735267
-
When is a carrier not a membrane carrier? The cytoplasmic transport of amphipathic molecules.Hepatology. 1996 Nov;24(5):1288-95. doi: 10.1002/hep.510240550. Hepatology. 1996. PMID: 8903412 Review.
-
Deciphering membrane insertion of the diphtheria toxin T domain by specular neutron reflectometry and solid-state NMR spectroscopy.J Mol Biol. 2009 Sep 4;391(5):872-83. doi: 10.1016/j.jmb.2009.06.061. Epub 2009 Jul 1. J Mol Biol. 2009. PMID: 19576225
Cited by
-
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.Br J Pharmacol. 2010 Jun;160(3):423-42. doi: 10.1111/j.1476-5381.2010.00787.x. Br J Pharmacol. 2010. PMID: 20590555 Free PMC article. Review.
-
2012 Division of medicinal chemistry award address. Trekking the cannabinoid road: a personal perspective.J Med Chem. 2014 May 22;57(10):3891-911. doi: 10.1021/jm500220s. Epub 2014 May 1. J Med Chem. 2014. PMID: 24707904 Free PMC article.
-
The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats.Neuropsychopharmacology. 2008 Mar;33(4):946-55. doi: 10.1038/sj.npp.1301476. Epub 2007 Jun 20. Neuropsychopharmacology. 2008. PMID: 17581535 Free PMC article.
-
Pharmacological Characterization of the Endocannabinoid Sensor GRABeCB2.0.Cannabis Cannabinoid Res. 2024 Oct;9(5):1250-1266. doi: 10.1089/can.2023.0036. Epub 2023 Dec 8. Cannabis Cannabinoid Res. 2024. PMID: 38064488
-
Endocannabinoid liberation from neurons in transsynaptic signaling.J Mol Neurosci. 2007 Sep;33(1):87-93. doi: 10.1007/s12031-007-0043-2. J Mol Neurosci. 2007. PMID: 17901551 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources